Microglia in Nasu-Hakola Disease
Introduction
Pathway Diagram
flowchart TD
MICROGLIA["Microglia<br/>Immune Cells"]
INFLAMMATION["Inflammation<br/>Response"]
TREM2["TREM2<br/>Receptor"]
C1Q["C1Q<br/>Complement"]
AMYLOID["Amyloid<br/>Plaques"]
TAU["Tau<br/>Protein"]
SNCA["Alpha-synuclein<br/>SNCA"]
TNF["TNF-alpha<br/>Cytokine"]
APOE["APOE<br/>Lipid Transport"]
AUTOPHAGY["Autophagy<br/>Clearance"]
NEUROINFLAM["Neuroinflammation<br/>Chronic State"]
NEURODEGREN["Neurodegeneration<br/>Disease"]
ALZHEIMER["Alzheimer's<br/>Disease"]
INFLAMMATION -->|"activates"| MICROGLIA
TREM2 -->|"regulates"| MICROGLIA
C1Q -->|"activates"| MICROGLIA
MICROGLIA -->|"produces"| TNF
MICROGLIA -->|"phagocytoses"| AMYLOID
MICROGLIA -->|"clears"| TAU
MICROGLIA -->|"processes"| SNCA
APOE -->|"modulates"| MICROGLIA
MICROGLIA -->|"promotes"| AUTOPHAGY
MICROGLIA -->|"drives"| NEUROINFLAM
NEUROINFLAM -->|"leads to"| NEURODEGREN
MICROGLIA -->|"regulates"| ALZHEIMER
classDef central fill:#006494,color:#e0e0e0
classDef protective fill:#1b5e20,color:#e0e0e0
classDef pathological fill:#ef5350,color:#0d0d1a
classDef regulatory fill:#4a1a6b,color:#e0e0e0
classDef outcome fill:#5d4400,color:#e0e0e0
class MICROGLIA central
class TREM2,AUTOPHAGY protective
class INFLAMMATION,TNF,NEUROINFLAM,NEURODEGREN pathological
class APOE,C1Q regulatory
class ALZHEIMER outcome
...
Microglia in Nasu-Hakola Disease
Introduction
Pathway Diagram
Mermaid diagram (expand to render)
<table class="infobox infobox-cell">Category </td>Location </td>Cell Type </td>Key Genes </td>Inheritance </td>Prevalence </td>
Nasu-Hakola disease (NHD), also known as polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), is a rare autosomal recessive disorder caused by mutations in TREM2 or TYROBP genes["@paloneva2002"]. This disease uniquely connects microglial dysfunction to both bone and brain pathology, making it a crucial model for understanding microglia-mediated neurodegeneration.
Overview <!-- taxonomy-enrichment -->
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
Morphology : microglial cell (source: Cell Ontology)Morphology can be inferred from Cell Ontology classification
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0000129)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)
[OBO Foundry (CL:0000129)](http://purl.obolibrary.org/obo/CL_0000129)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0000129)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)
[OBO Foundry (CL:0000129)](http://purl.obolibrary.org/obo/CL_0000129)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)
Genetics and Molecular Pathogenesis
TREM2 Mutations
Location : Chromosome 6p21.1Protein : Triggering receptor expressed on myeloid cells 2Function : Lipid sensing receptor on microgliaEffect : Loss-of-function leads to impaired phagocytosisTYROBP Mutations
Location : Chromosome 19q13.12Protein : TYROBP (DAP12), adaptor proteinFunction : Signal transduction for TREM2Effect : Disrupts TREM2 signaling cascadeMolecular Cascade
Ligand binding : TREM2 binds lipids, apolipoproteinsSignal transduction : TYROBP activates ITAM pathwayCellular responses : Phagocytosis, cytokine production, survivalDysfunction : Impaired lipid sensing and clearance
Microglial Function in the Healthy Brain
Normal Microglia Roles
Immune surveillance : Continuous process monitoringPhagocytosis : Clearance of debris, dead cells, aggregatesSynaptic pruning : Developmental and pathological remodelingCytokine signaling : Inflammation modulationSupport functions : Metabolic support, trophic factor releaseTREM2-Dependent Functions TREM2 is critical for several microglial activities:
Lipid metabolism : Sensing and processing myelin debrisAmyloid clearance : Critical in Alzheimer's disease modelsCell survival : Preventing apoptosisProliferation : Response to brain injuryRole in Nasu-Hakola Disease
Microglial Pathology The TREM2/TYROBP pathway is essential for microglial lipid sensing and phagocytosis[@griciuc2019]:
Phagocytic Impairment
Myelin debris accumulation : Incomplete clearanceLipid droplet formation : Defective processingLysosomal dysfunction : Autophagy impairmentCellular stress : ER stress, oxidative damageChronic Inflammation
Cytokine dysregulation : Elevated IL-1β, TNF-α, IL-6Failed resolution : Persistent inflammatory stateNLRP3 inflammasome : HyperactivationNeurodegeneration
White matter lesions : Sclerosing leukoencephalopathyCerebral atrophy : Progressive brain volume lossDemyelination : Primary pathologyNeuronal loss : Secondary to gliosisBone Pathology The same genes affect osteoclasts:
Bone cysts : Polycystic changes in long bonesPremenopausal fractures : Pathological fracturesImpaired remodeling : Defective osteoclast functionClinical Features
Therapeutic Implications
Current Approaches
Anti-inflammatory therapy : Targeting cytokine pathwaysIL-1 antagonists (anakinra)
TNF-α inhibitors
Bone marrow transplantation : Microglial replacementHematopoietic stem cell transplant
Experimental ([Griciuc et al., Neuron 2019](https://doi.org/10.1016/j.neuron.2019.08.010))
Symptomatic treatment : Supportive careCognitive enhancers
Physical therapy
Emerging Therapies
TREM2 agonists : Small molecule activatorsGene therapy : AAV-mediated TREM2 deliveryMicroglial replacement : iPSC-derived microgliaLipid metabolism modulators : Targeting the primary defectResearch Directions
Biomarkers : CSF biomarkers for early detectionImaging : PET ligands for microglial activationGenotype-phenotype correlations : Variable expressivityTherapeutic windows : Early intervention potentialRelationship to Alzheimer's Disease NHD provides insights into AD pathogenesis[@griciuc2019]:
TREM2 variants : AD risk factor (R47H, R62H)Microglial activation : Common pathwayLipid metabolism : Shared mechanismsTherapeutic translation : TREM2 as drug targetAnimal Models
Trem2 knockout mice : Microglial dysfunctionTyrobp knockout mice : Similar phenotypeHuman iPSC models : Patient-derived microgliaConditional knockouts : Cell-type specific studiesSee Also
[TREM2](/genes/trem2)
[Neuroinflammation](/mechanisms/microglia-neuroinflammation)
[/diseases/nasu-hakola-disease](/content/diseases)
[Microglia](/cell-types/microglia)
[/mechanisms/lipid-metabolism-neurodegeneration](/content/mechanisms)
External Links
[NHD Registry](https://www.nhdregistry.org/) - Patient registry
[OMIM - Nasu-Hakola](https://omim.org/) - Genetic information
[PubMed - TREM2 NHD](https://pubmed.ncbi.nlm.nih.gov/) - Research literature
Background The study of Microglia In Nasu Hakola Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
[Phase-Separated Organelle Targeting](/hypothesis/h-ec731b7a) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: G3BP1
[Purinergic P2Y12 Inverse Agonist Therapy](/hypothesis/h-f99ce4ca) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: P2RY12
[Complement C1q Mimetic Decoy Therapy](/hypothesis/h-1fe4ba9b) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: C1QA
[Metabolic Circuit Breaker via Lipid Droplet Modulation](/hypothesis/h-3d993b5d) — <span style="color:#81c784;font-weight:600">0.66</span> · Target: PLIN2
[Temporal Decoupling via Circadian Clock Reset](/hypothesis/h-019ad538) — <span style="color:#81c784;font-weight:600">0.65</span> · Target: CLOCK
[Fractalkine Axis Amplification via CX3CR1 Positive Allosteric Modulators](/hypothesis/h-ba3a948a) — <span style="color:#81c784;font-weight:600">0.63</span> · Target: CX3CR1
[Synthetic Biology Rewiring via Orthogonal Receptors](/hypothesis/h-e3506e5a) — <span style="color:#ffd54f;font-weight:600">0.59</span> · Target: CNO
[Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics](/hypothesis/h-513a633f) — <span style="color:#ffd54f;font-weight:600">0.58</span> · Target: ANXA1
Related Analyses:
[TREM2 agonism vs antagonism in DAM microglia](/analysis/SDA-2026-04-01-gap-001) 🔄
[Microglial subtypes in neurodegeneration — friend vs foe](/analysis/SDA-2026-04-02-gap-microglial-subtypes-20260402004119) 🔄
[TREM2 agonism vs antagonism in DAM microglia](/analysis/SDA-2026-04-02-gap-001) 🔄
[Microglia-astrocyte crosstalk amplification loops in neurodegeneration](/analysis/SDA-2026-04-01-gap-009) 🔄
[Synaptic pruning by microglia in early AD](/analysis/SDA-2026-04-01-gap-v2-691b42f1) 🔄
Pathway Diagram The following diagram shows the key molecular relationships involving Microglia in Nasu-Hakola Disease discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description